"The US patent is for the method of treating ischemia by administering
pooled allogeneic mesenchymal stromal cells," Stempeutics Research
said in a statement. Critical Limb Ischemia is a severe blockage in
the arteries which results in reduced blood flow which in turn may
result in poor quality of life.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/uspto-grants-patent-to-stempeutics-for-stem-cell-drug-stempeucel/articleshow/71851014.cms
No comments:
Post a Comment